Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1144L |
Corticotropin-releasing factor (human) acetate
Corticotropin-releasing factor (human) acetate (86784-80-7 Free base) |
CRFR | GPCR/G Protein |
Corticotropin-releasing factor (human) acetate 刺激垂体前叶合成和分泌促肾上腺皮质激素。 | |||
TP1144 |
Corticotropin-releasing factor (human)
Human corticotropin-releasing factor,Human CRF,Corticotropin-releasing factor human |
||
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous system and adrenal medulla. Functions b | |||
T37111 |
Corticotropin-releasing factor (human) (acetate)
|
||
Human CRF acetate is a chemical compound that effectively stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary. | |||
T20482 |
Acth (1-4)
(1-4) Corticotropin |
||
Acth (1-4) is the ACTH N-terminal tetrapeptide. | |||
TP1242 |
1-39-Corticotropin (human)(TFA)
Adrenocorticotropic Hormone (ACTH) (1-39), human(TFA) |
||
Adrenocorticotropic Hormone (ACTH) (1-39) human(TFA),a member of the melanocortin family, is a melanocortin receptor agonist. It stimulates production of CS by the adrenals, but melanocortin receptors are also found in the central nervous system (CNS) and | |||
TP1191 |
CRF, bovine
Corticotropin Releasing Factor bovine |
||
CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. | |||
T80694 |
β-Corticotropin (swine)
|
||
β-Corticotropin (swine) 为ACTH(肽激素促肾上腺皮质激素)的合成品,具有刺激类固醇释放的功能。 | |||
T83665 |
α-Helical CRF (9-41) TFA
α-Helical Corticotropin-Releasing Factor (9-41) |
||
α-Helical CRF (9-41) 是一种合成的皮质酮释放因子(CRF)拮抗剂。它在0.5至5 µM浓度范围内,能抑制CRF诱导的大鼠前叶垂体细胞释放促肾上腺皮质激素(ACTH)。在体内研究中,α-Helical CRF (9-41) (0.02-0.6 µmol/kg) 能够抑制未经麻醉的完整大鼠体内CRF诱导的ACTH释放,并在0.6 µmol/kg剂量下抑制大鼠应激诱导的ACTH释放。此外,α-Helical CRF (9-41) 在尼古丁诱导的条件性焦虑大鼠模型中增加社交互动时间,并减少小鼠的类似暴饮暴食的乙醇消费。 | |||
T83484 |
[Tyr0] Corticotropin Releasing Factor, ovine
|
||
[Tyr0] Corticotropin Releasing Factor, ovine 是从绵羊分离的促肾上腺皮质激素释放因子/激素。该因子(CRF)为下丘脑激素,能激发促肾上腺皮质激素(ACTH)及β-内啡肽的释放。 | |||
TP1190 |
CRF, bovine TFA (92307-52-3 free base)
CRF, bovine TFA,Corticotropin Releasing Factor bovine TFA |
||
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM[1]. CRF shows pEC50s of 11.16, 8.53 and 8 | |||
T76204 |
a-Helical Corticotropin Releasing Factor (9-41)
|
||
α-Helical Corticotropin Releasing Factor (9-41) 为corticotropin releasing factor (CRF)的拮抗剂,具有降低体内血浆生长激素(GH)水平的功能。 | |||
T76361 |
[DPro5] Corticotropin Releasing Factor, human, rat
|
||
[DPro5] Corticotropin Releasing Factor, human, rat 是人类和大鼠促肾上腺皮质激素释放因子/激素 R2 的选择性激动剂。作为一种下丘脑激素,促肾上腺皮质激素释放因子 (CRF) 能够促进肾上腺皮质激素 (ACTH) 和 β-内啡肽的分泌。值得注意的是,[DPro5] Corticotropin Releasing Factor, human, rat 并不触发典型的焦虑反应,而是能调控大鼠的学习与记忆过程。 | |||
T76362 |
[Met(O)21] Corticotropin Releasing Factor, ovine
|
||
[Met(O)21] Corticotropin Releasing Factor, ovine 是一种从绵羊下丘脑提取物中分离出的促肾上腺皮质激素释放因子(CRF)。该因子为一类下丘脑激素,主要功能为促进肾上腺皮质激素(ACTH)的分泌。 | |||
T76360 |
a-Helical Corticotropin Releasing Factor (12-41)
|
||
a-Helical Corticotropin Releasing Factor (12-41),一种含有30个氨基酸的α螺旋促肾上腺皮质激素释放因子/激素类似物。作为下丘脑激素的促肾上腺皮质激素释放因子 (CRF) 能促进肾上腺皮质激素 (ACTH) 分泌,而a-Helical Corticotropin Releasing Factor (12-41) 则抑制该刺激效应。 | |||
T4329 |
CP 376395
CP-316311 |
CRFR | GPCR/G Protein |
CP 376395 (CP-316311)是一种 CRF1受体选择性拮抗剂。 | |||
T12492 |
Pivagabine
CXB-722,匹伐加宾 |
GABA Receptor | Membrane transporter/Ion channel; Neuroscience |
Pivagabine (CXB-722) 是疏水性 4-氨基丁酸的衍生物,具有神经调节活性。它可穿透大鼠的血脑屏障,拮抗足部休克对大鼠脑中 GABAA 受体功能和促肾上腺皮质激素释放因子 (CRF) 浓度的影响。 | |||
T7361 |
Verucerfont
NBI77860,3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺,GSK561679 |
CRFR | GPCR/G Protein |
Verucerfont (NBI77860) 是促肾上腺皮质激素释放因子受体 1 (CRF1) 拮抗剂,作用于 CRF1(IC50:6.1 nM),CRF2 (IC50>1000 nM)和 CRF-BP (IC50>1000 nM)。 | |||
TP1021 |
Urocortin, human
Urocortin (human),Human urocortin,Human urocortin 1,Human urocortin I |
CRFR | GPCR/G Protein |
Urocortin, human (Human urocortin I) 是由 40 个氨基酸组成的神经多肽,是选择性 CRF2受体激动剂,作用于 hCRF1(Ki:0.4 nM)、rCRF2α(Ki:0.3 nM)、 mCRF2β(Ki:0.5 nM)。 | |||
T31095 |
Crinecerfont
SSR125543,SSR 125543,SSR-125543,SSR125543A,SSR 125543A,SSR-125543A |
CRFR | GPCR/G Protein |
Crinecerfont (SSR-125543) 是促肾上腺皮质激素释放因子 1 受体 (CRF1) 的特异性拮抗剂,可用于经典先天性肾上腺增生的研究。 | |||
T22577 |
Antalarmin hydrochloride
|
CRFR; Immunology/Inflammation related | GPCR/G Protein; Immunology/Inflammation |
Antalarmin hydrochloride 是促肾上腺皮质激素释放因子 1 (CRF1) 的拮抗剂。 Antalarmin hydrochloride 具有抗炎作用并抑制与肠易激综合征相关的应激性胃溃疡。 | |||
T16475 |
Pexacerfont
BMS-562086 |
CRFR | GPCR/G Protein |
Pexacerfont (BMS-562086) 是一种选择性的促肾上腺皮质激素释放因子 (CRF1) 受体拮抗剂,作用于人 CRF1 受体,IC50 为 6.1±0.6 nM。 | |||
TP1448L |
Astressin acetate
Astressin acetate (170809-51-5 Free base) |
CRFR | GPCR/G Protein |
Astressin acetate 是促肾上腺皮质激素释放因子 (CRF) 的拮抗剂,对 CRF 结合蛋白具有低亲和力,对克隆垂体受体具有高亲和力 (Ki = 2 nM)。 | |||
T9857 |
Vasopressin
antidiuretic hormone (ADH),argipressin,arginine vasopressin (AVP) |
Endogenous Metabolite | Metabolism |
Vasopressin (argipressin) 是一种由下丘脑神经元合成的环状九肽,是肽原激素合成中的一种激素。Vasopressin 参与下丘脑-垂体-肾上腺轴调节过程,增加无溶质水从肾小管的滤液中重新吸收回循环中的量,收缩小动脉提高压强,增强促肾上腺皮质激素释放因子的刺激作用调节垂体促肾上腺皮质激素分泌。Vasopressin 在神经传导过程中可作为神经递质,与特定的 G 蛋白偶联受体结合发挥作用。 | |||
TP2047L |
CRF (6-33) acetate(120066-38-8 free base)
|
CRFR | GPCR/G Protein |
CRF (6-33) acetate(120066-38-8 free base) 是促肾上腺皮质激素释放因子结合蛋白 (CRFBP) 抑制肽;从 CRFBP 中替换 CRF。在体内抑制肥胖大鼠的体重增加并增加运动活动。 | |||
TP1238L |
ACTH 1-14 acetate(25696-21-3 free base)
Adrenocorticotropic Hormone Fragment 1-14 acetate |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
ACTH 1-14 acetate(25696-21-3 free base) (Adrenocorticotropic Hormone Fragment 1-14 acetate) 是促肾上腺皮质激素的片段,可调节皮质醇和雄激素的产生。促肾上腺皮质激素 (ACTH),也称为促肾上腺皮质激素,由垂体前叶产生和分泌。作为对生物应激的反应,ACTH 是下丘脑-垂体-肾上腺轴的重要组成部分。 | |||
T27227 |
E2508
E 2508,E-2508 |
||
E2508 is a selective antagonist of corticotropin-releasing factor 1 receptor. | |||
T23057 |
NBI-27914 hydrochloride
|
Others | Others |
corticotropin-releasing factor1 (CRF1) receptor antagonist | |||
T24216 |
JTC-017
JTC 017 |
||
JTC-017 is an antagonist of Corticotropin-releasing hormone receptor 1. | |||
T26856 |
BMS-764459
|
||
BMS-764459 is a potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1). | |||
T12276 |
NVS-CRF38
|
Others | Others |
NVS-CRF38 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1). | |||
T23067 |
NGD 98-2 hydrochloride
|
Others | Others |
corticotropin-releasing factor receptor 1 (CRF1) antagonist | |||
T25864 |
NGD9002
NGD-9002,NGD 9002 |
||
NGD9002 is a novel generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist agent. | |||
T71294 |
BMS-763534
|
||
BMS-763534 is a potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1). | |||
T15214 |
Emicerfont
GW876008 |
Others | Others |
Emicerfont is an antagonist of the corticotropin-releasing factor type 1 receptor (IC50: 66 nM). | |||
T82698 |
Codactide
BA-41795 |
||
Codactide是一种合成八肽,表现出促肾上腺皮质激素(ACTH)样活性。 | |||
T33606 | NBI-30545 | ||
NBI-30545 is a potent corticotropin-releasing factor-1 antagonist with sufficient lipophilicity and water solubility for the treatment of stress disorders. | |||
T15145 |
DMP 696
|
Others | Others |
DMP 696 is a selective antagonist of corticotropin-releasing hormone receptor 1. It is used for the treatment of anxiety and depression. | |||
T69248 |
ONO-2333
|
||
ONO-2333 is a corticotropin-releasing factor receptor antagonist, for the treatment of depression and/or anxiety disorders | |||
T69374 |
NGD 98-2
|
||
NGD 98-2 is a new generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist. | |||
TP2095 |
Astressin 2B
|
||
Potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist (IC50 values are 1.3 and > 500 nM for CRF2 and CRF1 respectively). Antagonizes CRF2-mediated inhibition of gastric emptying. | |||
TP1860 |
Urocortin II, human
|
||
Human urocortin (hUcn) II is a new member of the corticotropin-releasing-factor (CRF) family. It selectively binds to the CRF2 receptor. | |||
TP2048 |
α-Helical CRF(9-41)
α-helical CRF 9-41 |
||
Corticotropin-releasing factor receptor antagonist (Ki values are 17, 5 and 0.97 at human CRF1, rat CRF2α and mouse CRF2β receptors respectively). | |||
TP2047 |
CRF(6-33)(human)
CRF (6-33) |
||
CRF(6-33)(human) is a Corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo. | |||
T75893 |
CRF(6-33)(human) TFA
|
||
CRF(6-33)(human) TFA 是一种 CRF 结合蛋白配体 (CRF-BP) 抑制剂,与CRF-BP 竞争性结合,但不与突触后 CRF 受体结合。CRF(6-33)(human) TFA 具有抗肥胖作用。 | |||
TP1011 |
ACTH (1-17)
α1-17-ACTH |
||
ACTH (1-17), an adrenocorticotropin analogue, is a potent human melanocortin 1 (MC1) receptor agonist with a Ki of 0.21 nM. Adrenocorticotropic hormone (ACTH), also known as corticotropin, is produced and secreted by the anterior pituitary gland. | |||
TP1241 |
Adrenocorticotropic Hormone (ACTH) (18-39), human
ACTH (18-39), human |
||
Adrenocorticotropic Hormone (ACTH) (18-39) is known as the Corticotropin-like Intermediate Lobe Peptide. It stimulates insulin secretion as well as amylase and protein secretion in a dose-dependent manner similar to those of secretin and carbamylcholine. | |||
T38228 |
R 121919 hydrochloride
|
||
High affinity corticotropin releasing factor receptor1 (CRF1) antagonist (Ki = 3.5 nM). Reduces stress-induced elevations of plasma ACTH. Anxiolytic and antidepressant in vivo. Orally bioavailable. Chen and Grigoriadis (2005) NBI 30775 (R121919), an orally active antagonist of the corticotropin-releasing factor (CRF) type-1 receptor for the treatment of anxiety and depression. Drug Dev.Res. 65 216 |Jutkiewicz et al (2005) The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919... | |||
TP2121 |
Sauvagine
|
||
Corticotropin-releasing factor (CRF) receptor agonist. Ki values are 9.4, 9.9, and 3.8 nM for inhibition of 125I-[D-Tyr1]astressin binding to hCRF-R1, rCRF-R2a and mCRF-R2b respectively. | |||
T26855 |
BMS-665053
BMS665053 |
||
BMS-665053 is a corticotropin-releasing factor-1 (CRF1) receptor antagonist (IC50 = 1.0 nM). BMS-665053)11 is a potent inhibitor of CRF-stimulated cyclic adenosine monophosphate (cAMP) production in human Y-79 retinoblastoma cells (IC50 = 4.9 nM). In addi | |||
TP2125 |
Stressin I
|
||
Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration. |